Functional evaluation of a novel vitreous substitute using polyethylene glycol sols injected into a foldable capsular vitreous body

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 9, 2013, Pages 2538-2547

  Chen, Han ^a,b   Feng, Songfu ^a,c   Liu, Yaqin ^a   Huang, Zhen ^a   Sun, Xuyuan ^a   Zhou, Lian ^a   Lu, Xiaohe ^c   Gao, Qianying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

biocompatibility; cytotoxicity; polyethylene glycol; retention time; vitreous substitute

Indexed keywords

ANTERIOR SEGMENT; CLINICAL EVALUATION; FUNCTIONAL EVALUATION; INTRA OCULAR PRESSURE; LIGHT TRANSMITTANCE; POLYETHYLENE GLYCOL (PEG); RETENTION TIME; VITREOUS SUBSTITUTE;

BIOCOMPATIBILITY; CYTOTOXICITY; FUNCTION EVALUATION; POLYETHYLENE GLYCOLS; REFRACTIVE INDEX;

SOLS;

BIOMATERIAL; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR SEGMENT ANALYSIS SYSTEM; ARTICLE; B SCAN; BIOCOMPATIBILITY; CILIARY DISK; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL RABBIT; EYE FUNDUS; FLOW KINETICS; FOLDABLE CAPSULAR VITREOUS BODY; HISTOPATHOLOGY; IMPLANTATION; INCIDENCE; INTERFACIAL TENSION; INTRAOCULAR PRESSURE; LIGHT; MOUSE; NICK END LABELING; NONHUMAN; OPHTHALMOSCOPY; OPTICAL DENSITY; PH; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REFRACTION INDEX; RETINA; SLIT LAMP; VISCOSITY; VITRECTOMY; VITREOUS BODY;

BIOCOMPATIBILITY; CYTOTOXICITY; POLYETHYLENE GLYCOL; RETENTION TIME; VITREOUS SUBSTITUTE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMECHANICAL PHENOMENA; CELL LINE; ELASTICITY; MATERIALS TESTING; MICE; OPTICAL PHENOMENA; POLYETHYLENE GLYCOLS; RABBITS; VISCOSITY; VITREOUS BODY;

EID: 84880574275     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34560     Document Type: Article

References (31)

1. Green WR, Sebag J,. Vitreoretinal interface. In:, Ryan SJ, editor. Retina, 4th ed, Vol. III, Chapter 114. Philadelphia: Elsevier Mosby; 2006. p 1921-1989.
2. Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S,. Vitreous substitutes: A comprehensive review. Surv Ophthalmol 2011; 56: 300-323.
3. Soman N, Banerjee R,. Artificial vitreous replacements. Biomed Mater Eng 2003; 13: 59-74.
4. Baino F,. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater 2011; 7: 921-935.
5. Silvanus MT, Moldzio P, Bornfeld N, Peters J,. Visual loss following intraocular gas injection. Dtsch Arztebl Int 2008; 105: 108-112.
6. Scott IU, Flynn HJ, Azen SP, Lai MY, Schwartz S, Trese MT,. Silicone oil in the repair of pediatric complex retinal detachments: A prospective, observational, multicenter study. Ophthalmology 1999; 106: 1399-1407.
7. Giordano Giovanni G, Refojo Miguel F,. Silicone oils as vitreous substitutes. Prog Polym Sci 1998; 23: 509-532.
8. Auriol S, Pagot-Mathis V, Mahieu L, Lemoine C, Mathis A,. Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1383-1389.
9. Li W, Zheng J, Zheng Q, Wu R, Wang X, Xu M,. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye 2010; 24: 21-28.
10. Pruett RC, Schepens CL, Swann DA,. Hyaluronic acid vitreous substitute: A six-year clinical evaluation. Arch Ophthalmol 1979; 97: 2325-2330.
11. Pruett RC, Calabria GA, Schepens CL,. Collagen vitreous substitute: I. Experimental study. Arch Ophthalmol 1972; 88: 540-543.
12. Chirila Traian V, Hong Ye, Dalton Paul D, Constable Ian J, Refojo Miguel F,. The use of hydrophilic polymers as artificial vitreous. Prog Polym Sci 1998; 23: 475-508.
13. Hong Y, Chirila TV, Vijayasekaran S, Shen W, Lou X, Dalton PD,. Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res 1998; 39: 650-659.
14. Hong Y, Chirila TV, Vijayasekaran S, Dalton PD, Tahija SG, Cuypers MJ, Constable IJ,. Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute. J Biomed Mater Res 1996; 30: 441-448.
15. Swindle-Reilly KE, Shah M, Hamilton PD, Eskin TA, Kaushal S, Ravi N,. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci 2009; 50: 4840-4846.
16. Leone G, Consumi M, Aggravi M, Donati A, Lamponi S, Magnani A,. PVA/STMP based hydrogels as potential substitutes of human vitreous. J Mater Sci Mater Med 2010; 21 (8): 2491-2500.
17. Maruoka S, Matsuura T, Kawasaki K, Okamoto M, Yoshiaki H, Kodama M, Sugiyama M, Annaka M,. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 2006; 31: 599-606.
18. Wathier M, Johnson MS, Carnahan MA, Baer C, McCuen BW, Kim T, Grinstaff MW,. In situ polymerized hydrogels for repairing scleral incisions used in pars plana vitrectomy procedures. Chem Med Chem 2006; 1: 821-825.
19. Duwuri S, Janoria KG, Pal D, Mitra AK,. Controlled delivery of ganciclovir to the retina with drug-loaded poly(D, L -lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: A novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. J Ocul Pharmacol Ther 2007; 23: 264-274.
20. Pritchard CD, Crafoord S, Andreasson S, Arner KM, O'Shea TM, Langer R, Ghosh FK,. Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits. Acta Biomater 2011; 7: 936-943.
21. Jonas JB, Budde WM, Knorr HL,. Timing of retinal redetachment after removal of intraocular silicone oil tamponade. Am J Ophthalmol 1999; 128: 628-631.
22. Gao Q, Mou S, Ge J, To CH, Hui Y, Liu A, Wang Z, Long C, Tan J,. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve. Eye 2008; 22: 461-468.
23. Gao Q, Chen X, Ge J, Liu Y, Jiang Z, Lin Z, Liu Y,. Refractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyes. Invest Ophthalmol Vis Sci 2009; 50: 3529-3534.
24. Liu Y, Jiang Z, Gao Q, Ge J, Chen J, Cao X, Shen Q, Ma P,. Technical standards of a foldable capsular vitreous body in terms of mechanical, optical, and biocompatible properties. Artif Organs 2010; 34: 836-845.
25. Chen J, Gao Q, Liu Y, Ge J, Cao X, Luo Y, Huang D, Zhou G, Lin S, Lin J, To CH, Siu AW,. Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater 2011; 97: 396-404.
26. Lin X, Ge J, Gao Q, Wang Z, Long C, He L, Liu Y, Jiang Z,. Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci 2011; 52: 374-381.
27. Wang P, Gao Q, Jiang Z, Lin J, Liu Y, Chen J, Zhou L, Li H, Yang Q, Wang T,. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experimental Ophthalmol 2012; 40: 67-75.
28. Lin X, Wang Z, Jiang Z, Long C, Liu Y, Wang P, Jin C, Yi C, Gao Q,. Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment. Retina 2012; 32: 729-741.
29. Chinese Pharmacopoeia (2005 edition). National Pharmacopoeia Committee. Beijing: Chemical Industry Press; 2005.
30. Annaka M, Mortensen K, Vigild ME, Matsuura T, Tsuji S, Ueda T, Tsujinaka H,. Design of an injectable in situ gelation biomaterials for vitreous substitute. Biomacromolecules 2011; 12: 4011-4021.
31. Swindle KE, Nathan Ravi,. Recent advances in polymetic vitreous substitutes. Exp Rev Ophthalmol 2007; 2: 255-265.